Atlas Trials

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT01885078 · COMPLETED

Trial details

NCT number
NCT01885078
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2013-06-27
Primary completion
2020-11-12
Enrollment
2877

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.